Jennison Associates’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-333,725
| Closed | -$106M | – | 609 |
|
|
2024
Q3 | $106M | Buy |
333,725
+13,945
| +4% | +$4.96M | 0.07% | 133 |
|
|
2024
Q2 | $119M | Buy |
319,780
+184,556
| +136% | +$62.3M | 0.08% | 104 |
|
|
2024
Q1 | $46.9M | Buy |
+135,224
| New | +$51.3M | 0.03% | 226 |
|
|
2023
Q4 | – | Sell |
-186,458
| Closed | -$90.7M | – | 602 |
|
|
2023
Q3 | $90.7M | Sell |
186,458
-189,087
| -50% | -$88.9M | 0.08% | 117 |
|
|
2023
Q2 | $168M | Sell |
375,545
-1,073
| -0.3% | -$540K | 0.14% | 74 |
|
|
2023
Q1 | $183M | Buy |
376,618
+11,649
| +3% | +$5.76M | 0.17% | 71 |
|
|
2022
Q4 | $187M | Sell |
364,969
-83,499
| -19% | -$43.9M | 0.19% | 74 |
|
|
2022
Q3 | $218M | Buy |
448,468
+42,555
| +10% | +$20.7M | 0.22% | 64 |
|
|
2022
Q2 | $190M | Sell |
405,913
-80,689
| -17% | -$35.9M | 0.19% | 71 |
|
|
2022
Q1 | $212M | Sell |
486,602
-175,686
| -27% | -$73.5M | 0.16% | 73 |
|
|
2021
Q4 | $307M | Sell |
662,288
-186,898
| -22% | -$82.7M | 0.19% | 60 |
|
|
2021
Q3 | $330M | Buy |
849,186
+4,045
| +0.5% | +$1.72M | 0.21% | 58 |
|
|
2021
Q2 | $374M | Sell |
845,141
-3,183
| -0.4% | -$1.39M | 0.25% | 53 |
|
|
2021
Q1 | $356M | Sell |
848,324
-478,107
| -36% | -$191M | 0.26% | 58 |
|
|
2020
Q4 | $544M | Sell |
1,326,431
-393,623
| -23% | -$164M | 0.39% | 49 |
|
|
2020
Q3 | $712M | Buy |
1,720,054
+724,288
| +73% | +$291M | 0.57% | 45 |
|
|
2020
Q2 | $386M | Sell |
995,766
-260,329
| -21% | -$97.4M | 0.35% | 50 |
|
|
2020
Q1 | $394M | Buy |
1,256,095
+1,049,394
| +508% | +$354M | 0.48% | 42 |
|
|
2019
Q4 | $75.8M | Sell |
206,701
-26,902
| -12% | -$8.53M | 0.08% | 141 |
|
|
2019
Q3 | $59.7M | Buy |
233,603
+21,238
| +10% | +$5.95M | 0.06% | 171 |
|
|
2019
Q2 | $56.3M | Sell |
212,365
-669
| -0.3% | -$170K | 0.06% | 194 |
|
|
2019
Q1 | $56.7M | Sell |
213,034
-84,204
| -28% | -$24.3M | 0.06% | 203 |
|
|
2018
Q4 | $85.2M | Sell |
297,238
-28,035
| -9% | -$8.89M | 0.1% | 124 |
|
|
2018
Q3 | $110M | Buy |
325,273
+566
| +0.2% | +$184K | 0.1% | 127 |
|
|
2018
Q2 | $96.6M | Sell |
324,707
-135,809
| -29% | -$39.8M | 0.09% | 151 |
|
|
2018
Q1 | $124M | Buy |
460,516
+49,291
| +12% | +$13.3M | 0.12% | 121 |
|
|
2017
Q4 | $102M | Buy |
411,225
+3,861
| +0.9% | +$953K | 0.1% | 149 |
|
|
2017
Q3 | $99.2M | Sell |
407,364
-2,677
| -0.7% | -$656K | 0.1% | 157 |
|
|
2017
Q2 | $98.7M | Sell |
410,041
-1,601
| -0.4% | -$362K | 0.1% | 159 |
|
|
2017
Q1 | $84.9M | Sell |
411,642
-2,411
| -0.6% | -$498K | 0.09% | 186 |
|
|
2016
Q4 | $84.5M | Buy |
414,053
+74,594
| +22% | +$14.2M | 0.09% | 188 |
|
|
2016
Q3 | $60M | Buy |
339,459
+26,577
| +8% | +$4.61M | 0.06% | 256 |
|
|
2016
Q2 | $56.3M | Sell |
312,882
-110,272
| -26% | -$19.6M | 0.06% | 261 |
|
|
2016
Q1 | $77.4M | Buy |
423,154
+36,807
| +10% | +$6.39M | 0.08% | 210 |
|
|
2015
Q4 | $69M | Buy |
386,347
+56,287
| +17% | +$9.88M | 0.07% | 233 |
|
|
2015
Q3 | $59.1M | Buy |
330,060
+2,460
| +0.8% | +$455K | 0.06% | 270 |
|
|
2015
Q2 | $62.7M | Buy |
327,600
+3,141
| +1% | +$583K | 0.06% | 295 |
|
|
2015
Q1 | $57.8M | Buy |
+324,459
| New | +$51.4M | 0.05% | 305 |
|
Other funds holding HUM
Jennison Associates's HUM Position: Q4 2024 in Review
Jennison Associates sold out of Humana (HUM) in Q4 2024, closing a stake of 333,725 shares — an estimated $106M sold.
Jennison Associates first reported a position in HUM in Q1 2015 and held it in 38 quarters. The position peaked at $712M in Q3 2020. 876 funds tracked by Wall St. Rank hold HUM as of Q4 2024.
- Jennison Associates reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
- Jennison Associates sold 333,725 Humana shares in Q4 2024, an estimated $106M.
- Jennison Associates first reported a position in Humana in Q1 2015 and held it in 38 quarters.
- Jennison Associates's Humana position peaked at $712M in Q3 2020.
- 876 funds tracked by Wall St. Rank held Humana as of Q4 2024.
Based on Jennison Associates's 13F filing for Q4 2024, filed 24 Jan 2025.